Glienke, Leilane
Bonzagni, Anthony F.
Hall, Timothy L.
Ghani, Khurshid R.
Roberts, William W.
Funding for this research was provided by:
Boston Scientific Corporation
Article History
Received: 15 May 2025
Accepted: 20 July 2025
First Online: 30 July 2025
Declarations
:
: LG: none, AFB: none, TLH: none, KRG: consulting relationships with Boston Scientific, Olympus, Ambu, Karl Storz, and Coloplast, and receives grants from Boston Scientific, Coloplast, and Patient Centered Outcomes Research Institute, WWR: consulting relationships with Boston Scientific and Calyxo. PI of research grants from Boston Scientific.
: The prototype fluid management system and prototype LVE software used in this study were concept devices/technologies, which were not available for sale at the time this study was conducted. The prototype fluid management system was further developed into the Asurys™ Fluid Management System, which is pending 510(k) clearance, does not have CE mark, and is not available for sale in the US, UK, EU, and many other regions. Bench testing results may not necessarily be indicative of clinical performance.